This study indicates that FNDC5-MSC-Exo has potential as a cell-free therapy strategy for MI, with Nrf2 and HO-1 playing crucial roles in its anti-inflammatory actions and regulation of macrophages (Ning et al., 2021). This evidence concerns the gene NFE2L2 and myocardial infarction.